Ambee Pharmaceuticals Limited reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported sales was BDT 48.93 million compared to BDT 43.81 million a year ago. Net income was BDT 0.589 million compared to BDT 0.247 million a year ago.

Basic earnings per share from continuing operations was BDT 0.25 compared to BDT 0.1 a year ago.